Authors
Latest:
Medicare Part D Insulin Tiering Change: Impact on Health OutcomesThis study explores the impact of a Medicare Part D formulary tier change, specifically with respect to branded insulin products, on insulin adherence, hemoglobin A1C, and diabetes-related events in elderly diabetic beneficiaries strategies for selection of appropriate and cost-effective therapy will also be discussed.
Latest:
Medicare Claim Processors' Reimbursement and G-CSF Choice Among Non-Hodgkin Lymphoma PatientsUsing the SEER-Medicare database, we found negative association between Medicare claim processors“related physician's chemotherapy reimbursement and their prescription of granulocyte colony-stimulating factor for non-Hodgkin lymphoma patients.
Latest:
Specialty Pharmacy Management of GoutNew drugs and drugs in the pipeline for gout have changed the treatment for this painful disease, one of the oldest documented diseases. Here's an update on what's new and what specialty pharmacists need to know as they counsel patients for gout.
Latest:
Increases in Utilization Management of Oncology Medicines by US PayersRecent increases in the number of therapies indicated for a given oncology subtype has resulted in heightened utilization management stringency.
Latest:
Smoking Cessation: Overcoming Nicotine DependencePharmacists can learn about the available interventions for smoking cessation.
Latest:
The Missing Link: Care Management’s Ability to Improve Specialty Pharmacy’s Value PropositionA real-life look at pharmacist-led care management's ability to overcome barriers to care and adherence in HIV treatment.
Latest:
Summary of Current SARS-CoV-2 Vaccine TrialsMany clinical trials are underway in a race to develop a safe and effective vaccine against severe acute respiratory SARS-CoV-2, the virus that causes COVID-19.
Latest:
Diabetes and Sodium-Glucose Cotransporter-2 InhibitorsDiabetes is a disease that affects a person's life each day by having a negative effect on quality of life and creating a financial burden for patients and families.
Latest:
16 New Investigators Awarded AACP GrantsSixteen new investigator award (NIA) winners are receiving up to $10,000 in grants from the American Association of Colleges of Pharmacy.
Latest:
Cost Impact of Switching From Metoprolol to Nebivolol for HypertensionA large single-payer administrative claims database was used to assess the economic impact of switching from metoprolol to nebivolol for the treatment of hypertension.
Latest:
Medication Underuse: The Most Underappreciated Quality-of-Care GapA patient-centric approach to medications is the key to identifying drug therapy problems.
Latest:
Maintaining Compliance in the Global Pharmacovigilance LandscapeA satisfactory system for the collection and reporting of adverse events is increasingly important as manufacturers place additional requirements on their specialty pharmacy and health care provider partners, and these needs go beyond the United States.
Latest:
Impact of Patient Cost Sharing on Multiple Sclerosis TreatmentThis study evaluates the impact of patient cost sharing on the probability of receiving disease-modifying therapies and treatment compliance among patients with multiple sclerosis.
Latest:
Pharmacists Can Help Assess New FDA-Approved IV OpioidOliceridine (Olinvyk) expands options for managing moderate to severe acute pain, but cost, drug-drug interactions, and other factors come into play.
Latest:
The Potential for Telehealth Within the Pharmacy SpaceTelehealth is a cost-saving solution that uses telecommunications technologies to expand health care outside the walls of a retail pharmacy while complementing and enhancing existing retail pharmacy services.
Latest:
The Role of Pharmacy Benefit Mangers in American Health Care: Pharmacy Concerns and Perspectives - Part 2American pharmacies across the nation are struggling as a result of pharmacy benefit manager (PBM) practices.
Latest:
Costs Associated With Second-Line Therapies for Lung CancerErlotinib may confer an economic advantage for payers over docetaxel and pemetrexed for second-line treatment of lung cancer because of lower costs.
Latest:
Modeled Cost Differences Associated With Use of Levonorgestrel Intrauterine DevicesThis analytic model assessed the per-woman cost differences between the use of 2 levonorgestrel-releasing intrauterine devices, from a US payer perspective.
Latest:
Pharmacist Oversupply: Outlook for StudentsPharmacy students are sharing thoughts about the prospective job market and pharmacist oversupply.
Latest:
Unique Roles for Pharmacy Technicians Can Enhance Patient Care and SafetyExpanding horizons can take many forms for pharmacy techs
Latest:
Pregnancy and Lactation LabelingThis article details what pharmacists need to know about the FDA's new proposed rule on pregnancy and lactation labeling.
Latest:
Opioid Overdose and Naloxone Delivery Devices in the Community SettingAlthough naloxone delivery devices are proven to reduce opioid overdoses, challenges persist in increasing the use of these devices in the community setting.
Latest:
Who Owns Patients’ Data?The bigger question is how patients can use that information to positively affect their lives.
Latest:
Etanercept and Ustekinumab Dosing for Psoriasis and Psoriatic ArthritisFor patients with psoriasis and/or psoriatic arthritis, actual-to-expected dosing ratios and costs were lower for etanercept than for ustekinumab.
